Replies to post #247897 on Biotech Values

[DewDiligence]

CRBU reports updated phase-1 data for allogeneic CAR-T for NHL—seeks to raise $115M* cash in public offering:

https://finance.yahoo.com/news/caribou-biosciences-reports-positive-clinical-200100822.html

https://finance.yahoo.com/news/caribou-biosciences-announces-proposed-public-200300180.html

*Assuming exercise of underwriter’s option.